Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules?
Remuzzi
G
G
Bertani
T
T
D000375:Aging / Q000473:pathology; D000818:Animals; D001798:Blood Proteins / Q000493:pharmacokinetics*; D002199:Capillary Permeability / Q000502:physiology*; D003928:Diabetic Nephropathies / Q000209:etiology; D004317:Doxorubicin / Q000009:adverse effects; D005923:Glomerulosclerosis, Focal Segmental / Q000209:etiology* / Q000378:metabolism / Q000473:pathology; D006801:Humans; D007678:Kidney Glomerulus / Q000378:metabolism* / Q000473:pathology; D046911:Macromolecular Substances; D011507:Proteinuria / Q000209:etiology; D011691:Puromycin / Q000009:adverse effects; D051381:Rats
D001798:Blood Proteins; D046911:Macromolecular Substances; D011691:Puromycin; D004317:Doxorubicin